SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or “smile line” wrinkles, today announced its participation at the 66th annual meeting of the American Academy of Dermatology (AAD) in San Antonio, Texas at the Henry B. Gonzalez Convention Center. This international conference is the premier venue for dermatologists to learn about new products and dermatologic procedures from experts in their field.
